Green Wednesday 2025: A Deep Dive into Recent Medical Cannabis Research

In celebration of Green Wednesday on November 26, 2025, the cannabis industry is abuzz with new insights into the medical applications of cannabis. This year’s roundup highlights significant research findings that explore the potential health benefits and implications of cannabis use. From kidney disease to anxiety, and even skin conditions like atopic dermatitis, recent studies are shedding light on how cannabis compounds can play a role in medical treatments

A pivotal study published in Cannabis and Cannabinoid Research investigates the relationship between cannabis use and kidney function. Conducted by researchers from Johns Hopkins University and Tulane University, this study utilizes longitudinal data from Baltimore, Maryland to explore potential health implications for individuals with kidney disease. The findings suggest that while cannabis use is prevalent, its direct impact on kidney function remains inconclusive, warranting further investigation to clarify these effects

In the realm of dermatology, a recent review in the Journal of Cannabis Research examines the use of cannabinoids in treating atopic dermatitis (AD). This chronic skin condition, characterized by itching and inflammation, has traditionally been treated with glucocorticoids, which can have adverse long-term effects. The review highlights the potential of cannabinoids such as CBD and THC, alongside compounds like PEA and dronabinol, to offer anti-inflammatory and anti-itch benefits, presenting a promising alternative to traditional treatments

Dr. Dustin Sulak, an advocate for cannabis in medical treatments, discussed the potential of cannabis in improving health outcomes for cancer patients, wound healing, and Alzheimer's symptoms in his September 2025 webinar. As the founder of Healer, a cannabis education platform, Dr. Sulak emphasized the need for continued research to substantiate these claims. His insights are part of a broader effort to understand how cannabis can be integrated into conventional medical practices to enhance patient care

Anxiety, affecting over a third of the U.S. adult population, is another area where cannabis shows promise. A pilot study published in Biomedicines explored the effects of a full-spectrum, high-CBD hemp extract on anxiety symptoms. The results indicate potential benefits, aligning with anecdotal reports from patients using cannabis for anxiety relief. This study underscores the growing interest in hemp-derived products as viable therapeutic options

Finally, a study in the Journal of Oral Pathology & Medicine addresses concerns about cannabis use and cancer risk. Conducted by researchers at the University of Florida, the study concludes that cannabis use alone does not increase the risk of head and neck cancers. However, when combined with alcohol and tobacco use, the risk is heightened, highlighting the importance of considering lifestyle factors in cancer research. This finding provides reassurance to cannabis users while emphasizing the need for comprehensive health assessments